Immunoconjugates are antibodies conjugated (joined) to a second molecule, usually a toxin, radioisotope or label.
[1] These conjugates are used in immunotherapy[citation needed] and to develop monoclonal antibody therapy as a targeted form of chemotherapy[2] when they are often known as antibody-drug conjugates.
When the conjugates include a radioisotope see radioimmunotherapy.
When the conjugates include a toxin see immunotoxin.
This immunology article is a stub.